Safety and Efficacy of Semorinemab in Individuals With Prodromal to Mild Alzheimer DiseaseEdmond Teng, Carlo de Lena, Pierre Anthony et al.|JAMA Neurology|2022Cited by 188
[18F]GTP1 (Genentech Tau Probe 1), a radioligand for detecting neurofibrillary tangle tau pathology in Alzheimer’s diseaseSandra Sanabria Bohórquez, Robby M. Weimer, Jan Mařı́k et al.|European Journal of Nuclear Medicine and Molecular Imaging|2019Cited by 130
Randomized Phase II Study of the Safety and Efficacy of Semorinemab in Participants With Mild-to-Moderate Alzheimer Disease: LaurietCecília Monteiro, William Alvin McElveen, Balázs István Tóth et al.|Neurology|2023Cited by 104
CenTauR: Toward a universal scale and masks for standardizing tau imaging studiesVictor L. Villemagne, Vincent Doré, Antoine Leuzy et al.|Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring|2023Cited by 66
Cross-sectional associations between [18F]GTP1 tau PET and cognition in Alzheimer's diseaseEdmond Teng, Robby M. Weimer, Michael E. Ward et al.|Neurobiology of Aging|2019Cited by 46